Mangalam Drugs & Organics Limited (NSE:MANGALAM)

Mangalam Drugs & Organics Statistics

Total Valuation

NSE:MANGALAM has a market cap or net worth of INR 1.41 billion. The enterprise value is 2.35 billion.

Market Cap	1.41B
Enterprise Value	2.35B

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	15.83M
Shares Outstanding	n/a
Shares Change (YoY)	-0.09%
Shares Change (QoQ)	-6.52%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	7.18M

Valuation Ratios

The trailing PE ratio is 21.00.

PE Ratio	21.00
Forward PE	n/a
PS Ratio	0.44
PB Ratio	0.95
P/TBV Ratio	1.20
P/FCF Ratio	6.30
P/OCF Ratio	3.31
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.55, with an EV/FCF ratio of 10.48.

EV / Earnings	34.93
EV / Sales	0.74
EV / EBITDA	6.55
EV / EBIT	12.22
EV / FCF	10.48

Financial Position

The company has a current ratio of 1.04, with a Debt / Equity ratio of 0.65.

Current Ratio	1.04
Quick Ratio	0.22
Debt / Equity	0.65
Debt / EBITDA	2.69
Debt / FCF	4.30
Interest Coverage	1.29

Financial Efficiency

Return on equity (ROE) is 4.72% and return on invested capital (ROIC) is 4.92%.

Return on Equity (ROE)	4.72%
Return on Assets (ROA)	3.43%
Return on Invested Capital (ROIC)	4.92%
Return on Capital Employed (ROCE)	10.99%
Revenue Per Employee	7.35M
Profits Per Employee	155,572
Employee Count	432
Asset Turnover	0.91
Inventory Turnover	1.28

Taxes

Income Tax	-19.35M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.94% in the last 52 weeks. The beta is -0.06, so NSE:MANGALAM's price volatility has been lower than the market average.

Beta (5Y)	-0.06
52-Week Price Change	-16.94%
50-Day Moving Average	83.28
200-Day Moving Average	96.23
Relative Strength Index (RSI)	58.26
Average Volume (20 Days)	70,148

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:MANGALAM had revenue of INR 3.18 billion and earned 67.21 million in profits. Earnings per share was 4.25.

Revenue	3.18B
Gross Profit	1.50B
Operating Income	192.16M
Pretax Income	47.86M
Net Income	67.21M
EBITDA	358.23M
EBIT	192.16M
Earnings Per Share (EPS)	4.25

Balance Sheet

The company has 25.89 million in cash and 962.30 million in debt, giving a net cash position of -936.41 million.

Cash & Cash Equivalents	25.89M
Total Debt	962.30M
Net Cash	-936.41M
Net Cash Per Share	n/a
Equity (Book Value)	1.49B
Book Value Per Share	100.32
Working Capital	73.84M

Cash Flow

In the last 12 months, operating cash flow was 425.94 million and capital expenditures -202.01 million, giving a free cash flow of 223.93 million.

Operating Cash Flow	425.94M
Capital Expenditures	-202.01M
Free Cash Flow	223.93M
FCF Per Share	n/a

Margins

Gross margin is 47.30%, with operating and profit margins of 6.05% and 2.12%.

Gross Margin	47.30%
Operating Margin	6.05%
Pretax Margin	1.51%
Profit Margin	2.12%
EBITDA Margin	11.28%
EBIT Margin	6.05%
FCF Margin	7.05%

Dividends & Yields

NSE:MANGALAM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.09%
Shareholder Yield	n/a
Earnings Yield	4.76%
FCF Yield	15.87%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6